JACOBS LEVY EQUITY MANAGEMENT, INC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 70 filers reported holding APREA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$272,000
-64.4%
53,201
-66.0%
0.00%
-60.0%
Q2 2021$765,000
-25.1%
156,678
-21.8%
0.01%
-37.5%
Q1 2021$1,022,000200,3550.01%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders